In previous studies, the PI3K/AKT pathway was shown to be a classical oncogenic signaling pathway that is involved in the occurrence, development and chemotherapy resistance of various tumors, and downregulated expression of NEAT1 inhibited the PI3K/AKT/mTOR signaling pathway in many cancer cells [50–52]. This evidence concerns the gene AKT1 and cancer.